Literature DB >> 19381440

CNS recurrence of primary mediastinal large b-cell lymphoma after complete remission.

Vittorio Stefoni1, Alessandro Broccoli2, Cinzia Pellegrini2, Enrico Derenzini2, Mariapaola Fina2, Pier Luigi Zinzani2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19381440     DOI： 10.1007/s11060-009-9898-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  25 in total

Review 1.  Primary mediastinal large B-cell lymphoma.

Authors:  Kerry J Savage
Journal:  Oncologist       Date:  2006-05

2.  Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

Authors:  V Boehme; S Zeynalova; M Kloess; M Loeffler; U Kaiser; M Pfreundschuh; N Schmitz
Journal:  Ann Oncol       Date:  2006-10-03       Impact factor: 32.976

Review 3.  CNS prophylaxis in lymphoma: who to target and what therapy to use.

Authors:  Quentin A Hill; Roger G Owen
Journal:  Blood Rev       Date:  2006-08-01       Impact factor: 8.250

4.  MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma.

Authors:  P Klimo; J M Connors
Journal:  Ann Intern Med       Date:  1985-05       Impact factor: 25.391

5.  Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'Adulte.

Authors:  C Haioun; C Besson; E Lepage; C Thieblemont; D Simon; C Rose; H Tilly; A Sonet; P Lederlin; M Attal; J Brière; F Reyes
Journal:  Ann Oncol       Date:  2000-06       Impact factor: 32.976

6.  Acute tumor lysis syndrome following intrathecal methotrexate.

Authors:  M Benekli; I H Güllü; M C Savaş; A Kadayifçi; M K Altundağ; G Tekuzman; D Firat
Journal:  Leuk Lymphoma       Date:  1996-07

7.  Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.

Authors:  Naoto Tomita; Fumio Kodama; Heiwa Kanamori; Shigeki Motomura; Yoshiaki Ishigatsubo
Journal:  Cancer       Date:  2002-08-01       Impact factor: 6.860

Review 8.  Central nervous system lymphoma.

Authors:  Andrew Lister; Lauren E Abrey; John T Sandlund
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2002

9.  Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features.

Authors:  M Lazzarino; E Orlandi; M Paulli; E Boveri; E Morra; E Brusamolino; S Kindl; R Rosso; C Astori; M C Buonanno
Journal:  J Clin Oncol       Date:  1993-12       Impact factor: 44.544

10.  Leukemias and lymphomas: treatment and prophylaxis of the central nervous system.

Authors:  Janet L Franklin; Jonathan Finlay
Journal:  Curr Treat Options Neurol       Date:  2006-07       Impact factor: 3.972
View more
  3 in total

1.  Early CNS relapse in a good-risk primary mediastinal large B-cell lymphoma after combined chemo- and radio-therapy.

Authors:  Makoto Sasaki; Koichi Sugimoto; Azuchi Masuda; Yutaka Tsukune; Yuriko Yahata; Norio Komatsu
Journal:  J Neurooncol       Date:  2010-02-13       Impact factor: 4.130

2.  Fusion PET-CT detection of neurolymphomatosis originating from primary breast lymphoma: A case report and literature review.

Authors:  Liying Xu; Yunfeng Zhou; Dasheng Qiu; Salman Shams
Journal:  Oncol Lett       Date:  2012-08-03       Impact factor: 2.967

Review 3.  Current trends in the treatment of primary mediastinal large B-cell lymphoma - an overview.

Authors:  Ivan Petković
Journal:  Contemp Oncol (Pozn)       Date:  2015-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.